他汀类药物的不良反应与临床合理应用(3)
[7] Wang JQ，Wu GR，Wang Z，et al. Long-term clinical outcomes of statin use for chronic heart failure： a meta-analysis of 15 pro-spective studies[J]. Heart Lung Circ，2013. doi： 10. 1016 / j.hlc. 2013. 07. 012[Epub ahead of Print]
[8] Wannamethee SG，Shaper AG，Whincup PH，et al. Impact ofdiabetes on cardiovascular disease risk and all-cause mortality inolder men： influence of age at onset，diabetes duration，and es-tablished and novel risk factors[J]. Arch Intern Med，2011，171( 5) ： 404-410.
[9] Baigent C，Blackwell L，Emberson J，et al. Efficacy and safetyof more intensive lowering of LDL cholesterol： a meta-analysis ofdata from 170，000 participants in 26 randomised trials[J]. Lan-cet，2010，376( 9753) ： 1670-1681.
[10] Reiner Z，Catapano AL，De Backer G，et al. ESC/EAS Guide-lines for the management of dyslipidaemias： the Task Force forthe management of dyslipidaemias of the European Society of Car-diology ( ESC) and the European Atherosclerosis Society ( EAS)[J]. Eur Heart J，2011，32( 14) ： 1769-1818., 百拇医药(王兰)
[8] Wannamethee SG，Shaper AG，Whincup PH，et al. Impact ofdiabetes on cardiovascular disease risk and all-cause mortality inolder men： influence of age at onset，diabetes duration，and es-tablished and novel risk factors[J]. Arch Intern Med，2011，171( 5) ： 404-410.
[9] Baigent C，Blackwell L，Emberson J，et al. Efficacy and safetyof more intensive lowering of LDL cholesterol： a meta-analysis ofdata from 170，000 participants in 26 randomised trials[J]. Lan-cet，2010，376( 9753) ： 1670-1681.
[10] Reiner Z，Catapano AL，De Backer G，et al. ESC/EAS Guide-lines for the management of dyslipidaemias： the Task Force forthe management of dyslipidaemias of the European Society of Car-diology ( ESC) and the European Atherosclerosis Society ( EAS)[J]. Eur Heart J，2011，32( 14) ： 1769-1818., 百拇医药(王兰)